Analystreport

Prometheus Biosciences, Inc. (NASDAQ: RXDX) had its price target raised by analysts at SVB Leerink LLC from $43.00 to $47.00. They now have an "outperform" rating o

Prometheus Biosciences, Inc.  (RXDX) 
Last prometheus biosciences, inc. earnings: 11/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ignyta.com